Damage to the Cardiovascular System in Patients with SARS-CoV-2 Coronavirus Infection. Part 2: Correction of Myocardial Systolic Dysfunction
Aim. To study changes in myocardial contractile function when prescribing mineralocorticoid receptor antagonists of spironolactone in patients after coronavirus infection SARS-CoV-2 with symptoms of chronic heart failure (CHF).Materials and methods. The study included 90 hospitalized patients with a...
Saved in:
Main Authors: | V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, I. I. Shvedov, E. E. Bykova, A. A. Ivannikov, L. V. Vasilyeva |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2022-05-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/2712 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Damage to the Cardiovascular System in Patients with SARS-CoV-2 Coronavirus Infection. Part 1: Predictors of the Development of an Unfavorable Prognosis
by: V. I. Podzolkov, et al.
Published: (2022-01-01) -
Effect of spironolactone therapy on the activity of the matrix metalloproteinase system in patients with heart failure after COVID-19
by: V. I. Podzolkov, et al.
Published: (2022-11-01) -
Resistant Hypertension: Questions and Contemporary Answers
by: V. I. Podzolkov, et al.
Published: (2019-09-01) -
Clinical manifestations of asthenic syndrome after coronavirus infection caused by SARS-CoV-2
by: A. O. Mikhailov, et al.
Published: (2023-07-01) -
The Coronavirus SARS-Cov-2: the Characteristics of Structural Proteins, Contagiousness, and Possible Immune Collisions
by: E. Р. Kharchenko
Published: (2020-05-01)